Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S James

Showing results (1331-1340 of 1,357) with videos related to

Pageof 136
Sort By:
Epilepsia|February 2, 2026
Characterizing early behavioral and social-emotional problems in young children with SCN1A+ Dravet syndrome: Findings from the ENVISION prospective natural history studyIngrid E Scheffer, M Scott Perry, Joseph Sullivan, et al.
Scientific Reports|March 22, 2020
Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 InfectionCynthia L Gay, Joann D Kuruc, Shane D Falcinelli, et al.
Harmful Algae|June 8, 2023
The Western Lake Erie culture collection: A promising resource for evaluating the physiological and genetic diversity of Microcystis and its associated microbiomeColleen E Yancey, E Anders Kiledal, Subba Rao Chaganti, et al.
The Journal of Infectious Diseases|September 25, 2021
Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent VorinostatCynthia L Gay, Katherine S James, Marina Tuyishime, et al.
Communications Medicine|May 23, 2022
A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concernNina Urke Ertesvåg, Julie Xiao, Fan Zhou, et al.
Epilepsia|November 18, 2025
Cognitive stagnation and executive function deficits in young children with SCN1A+ Dravet syndrome: Detailed characterization of onset, progression, and impact in the ENVISION natural history studyJoseph Sullivan, M Scott Perry, Ingrid E Scheffer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 7, 2026
Tracking tau and cellular responses in human iPSC-microglia: from uptake to seedable secretion, including in extracellular vesiclesMaria Kreger Karabova, Anna Del Ser-Badia, Anne Hedegaard, et al.
Therapeutic Advances in Rare Disease|September 22, 2025
Gene therapy for children with X-linked myotubular myopathy: a plain language summary of publication for the ASPIRO studyPerry B Shieh, Wendy Hughes, Marie Wood, et al.
Earth'S Future|January 2, 2023
A High-End Estimate of Sea Level Rise for PractitionersR S W van de Wal, R J Nicholls, D Behar, et al.
Nature Communications|August 18, 2021
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concernDonal T Skelly, Adam C Harding, Javier Gilbert-Jaramillo, et al.
Pageof 136

Showing results (1331-1340 of 1,357) with videos related to

Sort By:
Pageof 136
Epilepsia|February 2, 2026
Characterizing early behavioral and social-emotional problems in young children with SCN1A+ Dravet syndrome: Findings from the ENVISION prospective natural history studyIngrid E Scheffer, M Scott Perry, Joseph Sullivan, et al.
Scientific Reports|March 22, 2020
Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 InfectionCynthia L Gay, Joann D Kuruc, Shane D Falcinelli, et al.
Harmful Algae|June 8, 2023
The Western Lake Erie culture collection: A promising resource for evaluating the physiological and genetic diversity of Microcystis and its associated microbiomeColleen E Yancey, E Anders Kiledal, Subba Rao Chaganti, et al.
The Journal of Infectious Diseases|September 25, 2021
Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent VorinostatCynthia L Gay, Katherine S James, Marina Tuyishime, et al.
Communications Medicine|May 23, 2022
A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concernNina Urke Ertesvåg, Julie Xiao, Fan Zhou, et al.
Epilepsia|November 18, 2025
Cognitive stagnation and executive function deficits in young children with SCN1A+ Dravet syndrome: Detailed characterization of onset, progression, and impact in the ENVISION natural history studyJoseph Sullivan, M Scott Perry, Ingrid E Scheffer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 7, 2026
Tracking tau and cellular responses in human iPSC-microglia: from uptake to seedable secretion, including in extracellular vesiclesMaria Kreger Karabova, Anna Del Ser-Badia, Anne Hedegaard, et al.
Therapeutic Advances in Rare Disease|September 22, 2025
Gene therapy for children with X-linked myotubular myopathy: a plain language summary of publication for the ASPIRO studyPerry B Shieh, Wendy Hughes, Marie Wood, et al.
Earth'S Future|January 2, 2023
A High-End Estimate of Sea Level Rise for PractitionersR S W van de Wal, R J Nicholls, D Behar, et al.
Nature Communications|August 18, 2021
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concernDonal T Skelly, Adam C Harding, Javier Gilbert-Jaramillo, et al.
Pageof 136